No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ME 23andMe
- 0.523
- -0.007-1.26%
Close May 22 16:00 ET
- 0.530
- +0.007+1.30%
Pre 08:44 ET
252.71MMarket Cap-471P/E (TTM)
0.539High0.494Low3.85MVolume0.531Open0.530Pre Close1.99MTurnover1.24%Turnover RatioLossP/E (Static)482.92MShares2.12052wk High0.67P/B162.10MFloat Cap0.35052wk Low--Dividend TTM309.76MShs Float18.160Historical High--Div YieldTTM8.49%Amplitude0.350Historical Low0.516Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Notable Earnings After Thursday's Close
23andMe Q4 2024 Earnings Preview
Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading
Health care stocks were decreasing Tuesday afternoon, with the NYSE Health Care Index fractionally lower and the Health Care Select Sector SPDR Fund (XLV) down 0.1% The iShares Biotechnology ETF (IBB)
23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication
23andMe Holding (ME) unit Lemonaid Health now offers Petros Pharmaceuticals' (PTPI) prescription erectile dysfunction drug Stendra through its telehealth platform, the company said Tuesday. 23andMe sh
Express News | Petros Pharmaceuticals Launches U.S. Distribution Of STENDRA Through Collaboration With 23andMe Subsidiary, Lemonaid Health
Express News | Lemonaid Health Now Offers Prescription Ed Medication StendraⓇ Through Collaboration With Petros Pharmaceuticals
Comments
$23andMe(ME.US$ buy for a long term
2
$23andMe(ME.US$ someone wants it drive up price old owner wants it now read news.
1
3
$23andMe(ME.US$ bargain sell later, buy it now.
2
1
$23andMe(ME.US$ if she wants company pay a premium
1
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg